rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2 Suppl
|
pubmed:dateCreated |
1997-4-15
|
pubmed:abstractText |
Use of a beta-lactamase stable antibiotic is called for in cases of acute otitis media (AOM) likely to be caused by beta-lactamase-producing Haemophilus influenzae or Moraxella catarrhalis. Two beta-lactamase-stable agents commonly used for empirical treatment of AOM are amoxicillin/clavulanate and cefixime.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0891-3668
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S21-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9041624-Acute Disease,
pubmed-meshheading:9041624-Amoxicillin,
pubmed-meshheading:9041624-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:9041624-Cefixime,
pubmed-meshheading:9041624-Cefotaxime,
pubmed-meshheading:9041624-Cephalosporins,
pubmed-meshheading:9041624-Child,
pubmed-meshheading:9041624-Child, Preschool,
pubmed-meshheading:9041624-Clavulanic Acids,
pubmed-meshheading:9041624-Drug Therapy, Combination,
pubmed-meshheading:9041624-Female,
pubmed-meshheading:9041624-Humans,
pubmed-meshheading:9041624-Infant,
pubmed-meshheading:9041624-Male,
pubmed-meshheading:9041624-Otitis Media,
pubmed-meshheading:9041624-Prospective Studies,
pubmed-meshheading:9041624-Treatment Outcome
|
pubmed:year |
1997
|
pubmed:articleTitle |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
|
pubmed:affiliation |
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|